RxDoctor Payments Data

Rachel Wheeler, PA

Physician Assistant · North Richland Hills, TXNPI 1609195734

Payments from drug & device makers

$1,476in general payments, 2019–2025

Across 81 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$454
  • Pfizer$237
  • Exact Sciences$227
  • Lilly USA, LLC$207
  • Boehringer Ingelheim$49
  • GSK$48
  • plus $254 from 9 others

What the payments were for

  • Food & beverage$1,476100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,476 in reported general payments places this provider in the 70th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$1,943
Medicare patients
13
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide62$90,530
EliquisApixaban16$25,752
TrulicityDulaglutide15$22,717
JardianceEmpagliflozin15$19,034
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,007
SymbicortBudesonide/Formoterol Fumarate26$6,942
Omeprazole77$1,871
Albuterol Sulfate HfaAlbuterol Sulfate68$1,629
Ventolin HfaAlbuterol Sulfate26$1,585
Gabapentin50$1,471
Vitamin D2Ergocalciferol (Vitamin D2)96$1,451
Tramadol Hcl92$1,102
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$1,004
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$901
Donepezil Hcl44$821

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$207$113,24777 claims
PfizerEliquis$237$25,75216 claims
Boehringer IngelheimJardiance$49$19,03415 claims
AstraZenecaBreztri Aerosphere, Symbicort$28$13,94937 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in North Richland Hills

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →